Investing $5,000 in These 2 Biotechs Could Make You Rich

Collegium Pharmaceuticals (NASDAQ: COLL) and Athenex (NASDAQ: ATNX) may not be the most popular stocks on the market in terms of media coverage, but both might just make you rich with a well-timed investment. Unlike many of their compatriots in the world of small market cap biotechs, these two companies have regularly recurring revenues. While neither has consistently profitable operations at present, evidence suggests that they can achieve it within the next few years, making each a great candidate for investors' portfolios

What's more, these two stocks have similar paths toward profitability: Increasing the sales volume of their existing products on the market while finalizing their late-stage pipeline projects and moving them toward commercialization. There's going to be a lot going on with these companies over the near term, and growth investors should pay close attention if they want to have a shot at reaping the benefits of their successes. Let's dive in and explore Collegium and Athenex's prospects.

Image source: Getty Images.

Source Fool.com